Neurology and Neurosurgery - Global Neurology Academy

161-176 of 546

LUMINESCE: Assessing Satralizumab in Generalized Myasthenia Gravis
LUMINESCE: Assessing Satralizumab in Generalized Myasthenia Gravis
NeuroFrontiers
LUMINESCE: Assessing Satralizumab in Generalized Myasthenia Gravis
Advancements in gMG Management: Zilucoplan as an Alternative to C5 Inhibitors
Advancements in gMG Management: Zilucoplan as an Alternative to C5 Inhibitors
NeuroFrontiers
Advancements in gMG Management: Zilucoplan as an Alternative to C5 Inhibitors
Examining Inebilizumab in Generalized Myasthenia Gravis: Insights from MINT
Examining Inebilizumab in Generalized Myasthenia Gravis: Insights from MINT
NeuroFrontiers
Examining Inebilizumab in Generalized Myasthenia Gravis: Insights from MINT
Ryan Quigley
- Ryan Quigley
Advancing MS Care: Diagnostic Clarity, Early Action, and Patient-Centered Treatment
Advancing MS Care: Diagnostic Clarity, Early Action, and Patient-Centered Treatment
Global Neurology Academy
Advancing MS Care: Diagnostic Clarity, Early Action, and Patient-Centered Treatment
Tirisham V. Gyang, MD; Gates B. Colbert, MD
- Tirisham V. Gyang, MD
- Gates B. Colbert, MD
Prevention on the Horizon: Early Intervention and Risk Reduction in MS Care
Prevention on the Horizon: Early Intervention and Risk Reduction in MS Care
Global Neurology Academy
Prevention on the Horizon: Early Intervention and Risk Reduction in MS Care
Vikram V. Bhise, MD
- Vikram V. Bhise, MD
Evolving Diagnostic and Prognostic Strategies in Multiple Sclerosis Care
Evolving Diagnostic and Prognostic Strategies in Multiple Sclerosis Care
Global Neurology Academy
Evolving Diagnostic and Prognostic Strategies in Multiple Sclerosis Care
Ashley Baker, MSN, PMHNP; Jay Avasarala, MD, PhD
- Ashley Baker, MSN, PMHNP
- Jay Avasarala, MD, PhD
Genetic Testing in Pediatrics: Identifying Neurodevelopmental Disorders Early
Genetic Testing in Pediatrics: Identifying Neurodevelopmental Disorders Early
Clinician's Roundtable
Genetic Testing in Pediatrics: Identifying Neurodevelopmental Disorders Early
Jennifer M. Kalish, MD, PhD, FAAP
- Jennifer M. Kalish, MD, PhD, FAAP
Understanding Antibody-Mediated Demyelinating Diseases: Key Differences From MS
Understanding Antibody-Mediated Demyelinating Diseases: Key Differences From MS
NeuroFrontiers
Understanding Antibody-Mediated Demyelinating Diseases: Key Differences From MS
Michael Levy, MD, PhD
- Michael Levy, MD, PhD
Navigating MS Diagnosis in Older Adults: Distinguishing Comorbidities and Mimics
Navigating MS Diagnosis in Older Adults: Distinguishing Comorbidities and Mimics
NeuroFrontiers
Navigating MS Diagnosis in Older Adults: Distinguishing Comorbidities and Mimics
Le Hua, MD
- Le Hua, MD
Genetic Pathways in MS: The Clinical Impact of a Chromosome 2 Variant
Genetic Pathways in MS: The Clinical Impact of a Chromosome 2 Variant
NeuroFrontiers
Genetic Pathways in MS: The Clinical Impact of a Chromosome 2 Variant
Sergio Baranzini, PhD
- Sergio Baranzini, PhD
Timing Matters: Influenza Vaccination Response in MS Patients on Ofatumumab
Timing Matters: Influenza Vaccination Response in MS Patients on Ofatumumab
NeuroFrontiers
Timing Matters: Influenza Vaccination Response in MS Patients on Ofatumumab
Modern MS Management: Leveraging Technology to Support Brain Health
Modern MS Management: Leveraging Technology to Support Brain Health
Global Neurology Academy
Modern MS Management: Leveraging Technology to Support Brain Health
Victoria Leavitt, PhD; Gates B. Colbert, MD
- Victoria Leavitt, PhD
- Gates B. Colbert, MD
Decoding Disability Worsening in MS: The Case for Combining CSF and Serum Biomarkers
Decoding Disability Worsening in MS: The Case for Combining CSF and Serum Biomarkers
NeuroFrontiers
Decoding Disability Worsening in MS: The Case for Combining CSF and Serum Biomarkers
Ryan Quigley
- Ryan Quigley
Clemastine Fumarate and Progressive MS: A Closer Look at Unexpected Risks and Mechanisms
Clemastine Fumarate and Progressive MS: A Closer Look at Unexpected Risks and Mechanisms
NeuroFrontiers
Clemastine Fumarate and Progressive MS: A Closer Look at Unexpected Risks and Mechanisms
Advances in Alzheimer’s Diagnosis: From Imaging to Artificial Intelligence
Advances in Alzheimer’s Diagnosis: From Imaging to Artificial Intelligence
NeuroFrontiers
Advances in Alzheimer’s Diagnosis: From Imaging to Artificial Intelligence
Marc Haut, PhD
- Marc Haut, PhD
Transforming Alzheimer’s Care: Anti-Amyloid Therapies and Emerging Genetic Approaches
Transforming Alzheimer’s Care: Anti-Amyloid Therapies and Emerging Genetic Approaches
NeuroFrontiers
Transforming Alzheimer’s Care: Anti-Amyloid Therapies and Emerging Genetic Approaches
Marc Haut, PhD
- Marc Haut, PhD

Previous
1
2
…
9
10
11
12
13
…
34
35
Next

11/11